echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > China Chemical > Institutions get together to investigate the pharmaceutical and chemical industries are favored

    Institutions get together to investigate the pharmaceutical and chemical industries are favored

    • Last Update: 2021-07-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to statistics, last week (4 Yue 5 Ri Zhi 4 Yue 9 Ri ) a total of 114 listed companies received from fund companies, securities companies, and other institutions of private sun 121 times research.


    According to statistics, last week (4 Yue 5 Ri Zhi 4 Yue 9 Ri ) a total of 114 listed companies received from fund companies, securities companies, and other institutions of private sun 121 times research.


    From an industry perspective, last week’s institutional surveys focused on industries such as electronics, medicine, chemicals, automobile manufacturing, software and information technology services.


    From the perspective of specific companies, among the top 15 listed companies in the number of institutional surveys , Xinyangfeng, FAW Jiefang, Levima, and Shanghai Pharmaceutical have all obtained more than 40 institutional surveys .


    Xinyangfeng, a leading domestic compound fertilizer company, received 82 surveys last week .


    FAW Jiefang, which has been surveyed by 62 institutions, said that the domestic medium and heavy truck market demand has been strong in recent years.


    Levima Technologies, a domestic EVA photovoltaic film material manufacturer, has received 49 surveys.


    Shanghai Pharmaceuticals has obtained surveys from 44 institutions, and the company expects that the proportion of medical insurance expenditures and innovative drugs in the overall medical insurance expenditures will increase in the future.
    At present, the company has initially completed the restructuring of the R&D system, and 25 innovative drugs are in the R&D pipeline.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.